HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Predictors of outcome of pharmacological and psychological treatment of late-life panic disorder with agoraphobia.

AbstractOBJECTIVE:
This study aims to evaluate the differential predictive values of age, age of onset and duration of illness on paroxetine and cognitive-behavioural therapy (CBT) outcome in late-life panic disorder with agoraphobia.
METHOD:
Patients 60 years and older with a confirmed diagnosis of panic disorder with agoraphobia (n = 49) were randomly assigned to paroxetine (40 mg/day) treatment, individual CBT or a waiting-list control condition. Multiple regression analyses were conducted per treatment arm with post-treatment avoidance behaviour and agoraphobic cognitions as the dependent variables.
RESULTS:
Higher age at onset and shorter duration of illness were predictors of superior outcomes following CBT, although these variables did not influence the treatment effects of paroxetine.
CONCLUSIONS:
In late-life agoraphobic panic disorder, chronological age has no impact on treatment modality outcome. In older patients with a late disease onset or shorter duration of illness, CBT is to be preferred over paroxetine, whereas paroxetine might be the treatment of choice for older people with an early onset and short duration of illness.
AuthorsGert-Jan Hendriks, Ger P J Keijsers, Mirjam Kampman, Cees A L Hoogduin, Richard C Oude Voshaar
JournalInternational journal of geriatric psychiatry (Int J Geriatr Psychiatry) Vol. 27 Issue 2 Pg. 146-50 (Feb 2012) ISSN: 1099-1166 [Electronic] England
PMID21452176 (Publication Type: Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2011 John Wiley & Sons, Ltd.
Chemical References
  • Serotonin Uptake Inhibitors
  • Paroxetine
Topics
  • Age Factors
  • Age of Onset
  • Aged
  • Agoraphobia (therapy)
  • Cognitive Behavioral Therapy
  • Female
  • Humans
  • Male
  • Middle Aged
  • Panic Disorder (therapy)
  • Paroxetine (therapeutic use)
  • Predictive Value of Tests
  • Regression Analysis
  • Selective Serotonin Reuptake Inhibitors (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: